Diana Campelo Delgado,  —

Machine learning, a method of data analysis, could improve disease prediction and bring precision medicine for cystic fibrosis (CF) one step closer to reality, according to researchers at the University of Cambridge, in the U.K., who have developed novel artificial intelligence (AI) technologies to allow for clinical…

The Cystic Fibrosis Foundation (CFF) is awarding Synspira Therapeutics up to $14 million in additional funding to support the development of two therapies to address complications of cystic fibrosis (CF), namely malabsorption and pulmonary infections. “Despite the approval of new treatments for the underlying cause of CF, many…